Abstract
Glycosylphosphatidylinositol (GPI) moieties consist of a hydrophobic core (two to three fatty acids attached to phosphatidylinositol) continued by a chain of five hexoses (the glycolinker) that is covalently linked via phosphoethanolamine to the C-terminal amino acid of a long list of mammalian proteins. This glycolipid moiety imparts characteristic membrane properties (diffusion, lateral mobility and clustering) to proteins and the glycolinker component constitutes a molecular motif recognized by lectins, cytokines and bacterial toxins. Due to the saturated acyl chains of its core lipids, GPIs preferentially insert in sphingolipid-rich domains of the plasma membrane outer leaflet, and the capacity of GPIanchored proteins to participate in transmembrane signalling depends on this property. GPI-anchored proteins can be made to associate with membranes and thus offer a therapeutic potential in tumor vaccine preparation and complement protection. Research on the role of GPI-anchored proteins in membrane structure and function has fruitfully contributed to the elaboration of today ’ s prevailing concepts of membrane organization.
Keywords: concanavalin A, tumor necrosis factor alpha, CD59 protein, insulin-receptor substrate, Bacterial Toxins
Current Organic Chemistry
Title: Functional and Structural Roles of GPI Moieties in Mammalian Plasma Membranes
Volume: 11 Issue: 7
Author(s): Daniel C. Hoessli, Sebastien Tauzin, Nasir-ud-Din and Bettina Borisch
Affiliation:
Keywords: concanavalin A, tumor necrosis factor alpha, CD59 protein, insulin-receptor substrate, Bacterial Toxins
Abstract: Glycosylphosphatidylinositol (GPI) moieties consist of a hydrophobic core (two to three fatty acids attached to phosphatidylinositol) continued by a chain of five hexoses (the glycolinker) that is covalently linked via phosphoethanolamine to the C-terminal amino acid of a long list of mammalian proteins. This glycolipid moiety imparts characteristic membrane properties (diffusion, lateral mobility and clustering) to proteins and the glycolinker component constitutes a molecular motif recognized by lectins, cytokines and bacterial toxins. Due to the saturated acyl chains of its core lipids, GPIs preferentially insert in sphingolipid-rich domains of the plasma membrane outer leaflet, and the capacity of GPIanchored proteins to participate in transmembrane signalling depends on this property. GPI-anchored proteins can be made to associate with membranes and thus offer a therapeutic potential in tumor vaccine preparation and complement protection. Research on the role of GPI-anchored proteins in membrane structure and function has fruitfully contributed to the elaboration of today ’ s prevailing concepts of membrane organization.
Export Options
About this article
Cite this article as:
Hoessli C. Daniel, Tauzin Sebastien, Nasir-ud-Din and Borisch Bettina, Functional and Structural Roles of GPI Moieties in Mammalian Plasma Membranes, Current Organic Chemistry 2007; 11 (7) . https://dx.doi.org/10.2174/138527207780598783
DOI https://dx.doi.org/10.2174/138527207780598783 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Cutting-edge technology for the development of electrochemical sensors
Electrochemistry based point of care diagnostics is a powerful tool which can revolutionize the current concept of personalize health care industry. There have been several efforts to amalgamate cutting edge technologies (nanotechnology, surface technology, anti-biofouling strategies) while developing assays. The success of each electrochemical sensor is very dependable upon how ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Angiogenesis in Glioblastoma: The Clinical Consequences of Redundancy and Evasion?
Current Angiogenesis (Discontinued) Carcinogenesis and Therapeutic Strategies in Thyroid Cancer
Current Drug Targets Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats
CNS & Neurological Disorders - Drug Targets Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Immuno-Isolation in Cancer Gene Therapy
Current Gene Therapy Recent Advances in Regulatory T Cell Therapy of Autoimmunity, Graft Rejection and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery The Potential of Microalgae for the Production of Bioactive Molecules of Pharmaceutical Interest
Current Pharmaceutical Biotechnology Blood Stem Cells and non-Hematological Clinical Practice: Pragmatics Before Therapeutics
Current Pharmaceutical Biotechnology Involvement of Mast Cells in Angiogenesis and Chronic Inflammation
Current Drug Targets - Inflammation & Allergy P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design
Current Topics in Medicinal Chemistry Advances in Research of Schiff-Base Metal Complexes as Potent Antioxidants
Current Medicinal Chemistry Tumor Vasculature Targeted TNFα Therapy: Reversion of Microenvironment Anergy and Enhancement of the Anti-tumor Efficiency
Current Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Fusing Multiple Biological Networks to Effectively Predict miRNA-disease Associations
Current Bioinformatics The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders
Current Drug Targets Bayes Syndrome and Imaging Techniques
Current Cardiology Reviews HIV-1 Reactivation Induced by Apicidin Involves Histone Modification in Latently Infected Cells
Current HIV Research Latest Advancements on Serotonin and Dopamine Transporters in Lymphocytes
Mini-Reviews in Medicinal Chemistry The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
Current Cancer Drug Targets